Literature DB >> 2994809

The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man.

J M Jacobs, F R Costa-Jussà.   

Abstract

Sural nerve changes are described in 2 cases of amiodarone neuropathy. Clinically, 1 patient developed a sensorimotor neuropathy, whereas in the other it was predominantly motor. Examination of sural nerves showed demyelination with only mild axonal loss. Cytoplasmic changes developed in Schwann cells of myelinated and unmyelinated axons, and involved loss of most recognizable organelles. These changes were associated with, and possibly preceded, myelin sheath breakdown. Inclusions, mainly of a lamellated type, were found in all cell types in the nerves. These inclusions, known to be lysosomal in origin, are a characteristic finding in amiodarone-induced neuropathy. The pathogenesis of the neuropathy is discussed, with particular reference to the findings in a parallel experimental study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994809     DOI: 10.1093/brain/108.3.753

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

1.  Unusual amiodarone toxicity in a child.

Authors:  Bahram Kakavand; Thomas G Di Sessa
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

Review 2.  Amiodarone-associated optic neuropathy: a critical review.

Authors:  Rod S Passman; Charles L Bennett; Joseph M Purpura; Rashmi Kapur; Lenworth N Johnson; Dennis W Raisch; Dennis P West; Beatrice J Edwards; Steven M Belknap; Dustin B Liebling; Mathew J Fisher; Athena T Samaras; Lisa-Gaye A Jones; Katrina-Marie E Tulas; June M McKoy
Journal:  Am J Med       Date:  2012-03-03       Impact factor: 4.965

3.  Ataxia: a diagnostic perplexity and management dilemma.

Authors:  Vinod K Chaubey; Lovely Chhabra; Aaysha Kapila
Journal:  BMJ Case Rep       Date:  2013-09-26

Review 4.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

5.  Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

6.  Morphological study of peripheral nerve changes induced by chloroquine treatment.

Authors:  R Tegnér; F M Tomé; P Godeau; F Lhermitte; M Fardeau
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

7.  Amiodarone-induced hepatitis and polyneuropathy.

Authors:  Hyun Mo Kang; Yoon Sae Kang; Seok Hyun Kim; Jae Kyu Seong; Dae Young Kang; Heon Young Lee; Byung Seok Lee
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 2.884

8.  Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite.

Authors:  Y Yamanaka; E Sakamoto; Y Sakuma; H Uno; T Koyama; Y Izawa; K Fujiwara
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 9.  Alterations in Cellular Processes Involving Vesicular Trafficking and Implications in Drug Delivery.

Authors:  Silvia Muro
Journal:  Biomimetics (Basel)       Date:  2018-07-24

Review 10.  Amiodarone: A Newly Discovered Association with Bilateral Vestibulopathy.

Authors:  Robert Gürkov
Journal:  Front Neurol       Date:  2018-03-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.